NCT00000766 - CMV Retinitis Retreatment Trial | Biotech Hunter

Enrollment

300

Participants

Timeline

Start Date

Not specified

Primary Completion Date

September 30, 1995

Conditions

Cytomegalovirus RetinitisHIV Infections

Interventions

DRUG

Foscarnet sodium

DRUG

Ganciclovir

Trial Locations (9)

New York Univ Med Ctr / SOCA, New York

New York Hosp - Cornell Med Ctr / Sloan - Kettering / SOCA, New York

Northwestern Univ / SOCA, Chicago

UCSF - San Francisco Gen Hosp, San Francisco

Mount Sinai Med Ctr / SOCA, New York

Johns Hopkins Hosp / SOCA, Baltimore

Univ of North Carolina / SOCA, Chapel Hill

UCLA - Jules Stein Eye Institute / SOCA, Los Angeles

UCSD - Shiley Eye Ctr / SOCA, La Jolla

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH